COMMUNIQUÉS West-GlobeNewswire

-
Le KFSH&RC produit avec succès les premiers lymphocytes T thérapeutiques du royaume
24/06/2024 -
Medigene Reports Results of Annual General Meeting
24/06/2024 -
LUKE Welcomes William Grubbs to Board of Directors
24/06/2024 -
Transactions in Connection with Share Buy-back Program
24/06/2024 -
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
24/06/2024 -
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia
24/06/2024 -
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
24/06/2024 -
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salomon Named Successor
24/06/2024 -
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
24/06/2024 -
Novo Nordisk A/S - share repurchase programme
24/06/2024 -
Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP)
24/06/2024 -
Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program
24/06/2024 -
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
24/06/2024 -
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
24/06/2024 -
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
24/06/2024 -
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
24/06/2024 -
Professional Boxer and Social Media Sensation Ryan Garcia Joins Safety Shot as Brand Ambassador
24/06/2024 -
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
24/06/2024 -
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
24/06/2024
Pages